CAR T-cell therapy neurotoxicity linked to NfL elevationsOctober 3, 2022Cellular TherapyAggressive LymphomasALLB Cell LymphomaMultiple MyelomaMixed TopicsCLL
Many die waiting for `last-chance’ therapyAugust 2, 2022Multiple MyelomaAggressive LymphomasALLCLLCellular TherapyMixed Topics
Ex–hospital porter a neglected giant of cancer researchMay 11, 2022ALLAggressive LymphomasB Cell LymphomaCLLDLBCLMantle Cell LymphomaMultiple Myeloma
First-line CAR T-cell therapy could help cure some lymphomasMarch 22, 2022Aggressive LymphomasDLBCLGene Therapy
100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'January 21, 2022TransplantAggressive LymphomasALLDLBCLCLLTranslational ResearchB Cell Lymphoma
DKMS: Small nonprofit to world’s largest stem cell donor registryJanuary 21, 2022ALLCOVID-19 UpdatesMixed TopicsMultiple MyelomaDLBCLB Cell LymphomaAML
NHL: As a second-line treatment in phase 3 trial, tisa-cel disappointsDecember 15, 2021Aggressive LymphomasCellular TherapyGene Therapy
Don’t delay: Cancer patients need both doses of COVID vaccineMarch 15, 2021Patient & Survivor CareAggressive LymphomasB Cell LymphomaT Cell LymphomasMultiple MyelomaMantle Cell LymphomaIndolent Lymphoma
Survey quantifies COVID-19’s impact on oncologySeptember 20, 2020COVID-19 UpdatesDLBCLAggressive LymphomasALLAMLAnemiaCLL
Hepatitis screening now for all patients with cancer on therapyAugust 6, 2020Patient & Survivor CareHodgkin LymphomaIndolent LymphomaMantle Cell LymphomaB Cell LymphomaAggressive Lymphomas
American Cancer Society update: ‘It is best not to drink alcohol’June 9, 2020T Cell LymphomasB Cell LymphomaAggressive Lymphomas
NCCN guidelines highlight ‘complicated’ treatment for pediatric lymphomasJanuary 14, 2020B Cell LymphomaAggressive LymphomasPediatricsDLBCL
